SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001213900-24-051806
Filing Date
2024-06-11
Accepted
2024-06-11 17:27:28
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-06-11

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0206592-03.pdf ARS 1556635
  Complete submission text file 0001213900-24-051806.txt   2126381
Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

IRS No.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-41596 | Film No.: 241036839
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)